v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NON-CONTROLLING INTERESTS AND EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Redeemable Non-Controlling Interests
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Redeemable Non-Controlling Interests
Beginning balance at Dec. 31, 2024   $ 93          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Re-measurement of non-controlling interests   18          
Net income (loss)   (18)          
Ending balance at Mar. 31, 2025   93          
Beginning balance (in shares) at Dec. 31, 2024     2,107,953        
Beginning balance at Dec. 31, 2024 $ 22,383   $ 0 $ 42,801 $ (517) $ (20,726) $ 825
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     657        
Exercise of stock options 8     8      
Stock-based compensation 448     448      
Issuance of common stock for settlement of RSUs (in shares)     10,293        
Shares withheld related to net share settlement (in shares)     (460)        
Shares withheld related to net share settlement (33)     (33)      
Repurchase of common stock (in shares)     (26,587)        
Repurchase of common stock (1,800)     (1,800)      
Re-measurement of non-controlling interests (18)     (18)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax 1       1    
Unrealized gain (loss) on cash flow hedges 0            
Foreign currency translation adjustment 31       31    
Net income (loss) 1,792         1,780 12
Ending balance (in shares) at Mar. 31, 2025     2,091,856        
Ending balance at Mar. 31, 2025 $ 22,812   $ 0 41,406 (485) (18,946) 837
Beginning balance at Dec. 31, 2025   165          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Re-measurement of non-controlling interests   10          
Net income (loss)   (4)          
Ending balance at Mar. 31, 2026   $ 171          
Beginning balance (in shares) at Dec. 31, 2025 2,067,905   2,067,905        
Beginning balance at Dec. 31, 2025 $ 27,918   $ 0 38,101 (432) (10,628) 877
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares) 61   63        
Exercise of stock options $ 1     1      
Stock-based compensation 484     484      
Issuance of common stock for settlement of RSUs (in shares)     8,721        
Shares withheld related to net share settlement (in shares)     (525)        
Shares withheld related to net share settlement (39)     (39)      
Repurchase of common stock (in shares)     (39,740)        
Repurchase of common stock (3,010)     (3,010)      
Re-measurement of non-controlling interests (10)     (10)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (12)       (12)    
Unrealized gain (loss) on cash flow hedges 13       13    
Foreign currency translation adjustment 10       10    
Net income (loss) $ 286         273 13
Ending balance (in shares) at Mar. 31, 2026 2,036,424   2,036,424        
Ending balance at Mar. 31, 2026 $ 25,641   $ 0 $ 35,527 $ (421) $ (10,355) $ 890